3136 results for «3020»

Filter By

3136 results

TAVI essentials: anatomical factors, prosthesis selection, and complication management

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

Discover a comprehensive exploration of critical considerations in TAVI in this section. From anatomical factors guiding the choice between TAVI and SAVR to strategies for selecting the optimal TAVI prosthesis for individual patients, each topic offers essential insights. Gain valuable insights into navigating TAVI for bicuspid...

TAVI essentials: anatomical factors, prosthesis selection, and complication management

Comprehensive assessment of mitral valve disorders and treatment outcomes

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

This session offers a comprehensive exploration of mitral valve disorders, covering diagnosis and severity assessment from multiple perspectives. From morphology-based diagnosis to echocardiography and CMR assessments, gain insights into distinguishing between rheumatic and calcific mitral stenosis, evaluating outcomes post-TMVR and surgical repair, and assessing bioprosthetic and...

Comprehensive assessment of mitral valve disorders and treatment outcomes

Optimizing case selection and procedure guidance in transcatheter mitral valve interventions

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...

Optimizing case selection and procedure guidance in transcatheter mitral valve interventions

Tricuspid valve disease: diagnosis and classification

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

Discover, in this comprehensive 3rd episode of PCR Imaging Valves Madrid 2024, the nuances of diagnosing and grading tricuspid valve disease, including insights into normal and abnormal function post-repair or replacement, the pivotal role of imaging in valve quantification and device selection, strategies for assessing right ventricular...

Tricuspid valve disease: diagnosis and classification

Advanced imaging strategies in transcatheter tricuspid valve therapies

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

In this PCR Imaging Valves Madrid 2024 session, discover the use of various imaging techniques in transcatheter tricuspid valve therapies, ranging from standard TEE screening to comprehensive intra-procedural assessments, facilitating optimal device selection, procedural success, and post-procedural monitoring.

Advanced imaging strategies in transcatheter tricuspid valve therapies

Multivalvular disease: diagnostic challenges and treatment strategies for aortic and mitral valve disorders

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

Addressing the complex diagnostic challenges in aortic stenosis and regurgitation, this session examines the timing of treatment initiation and the decision-making process when aortic valve disease coincides with aortic pathology. It also explores the ongoing healthcare burden posed by mitral regurgitation and stenosis, emphasizing the importance...

Multivalvular disease: diagnostic challenges and treatment strategies for aortic and mitral valve disorders

Multivalvular disease: mitral and aortic valve challenges explored

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

Explore cutting-edge transcatheter valve interventions for mitral and aortic valve disorders, including valve-in-valve procedures and management strategies for paravalvular leakages, and learn about diagnosing and treating mitral annular calcification and transcatheter options in infective endocarditis.

Multivalvular disease: mitral and aortic valve challenges explored

TAVI for patients with concomitant coronary artery disease - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...

TAVI for patients with concomitant coronary artery disease - LIVE case

PCR Tokyo Valves 2024 Welcome Ceremony

17 Feb 2024 – From PCR Tokyo Valves 2024

After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...

PCR Tokyo Valves 2024 Welcome Ceremony

Challenges in TEER for secondary mitral regurgitation

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...

Challenges in TEER for secondary mitral regurgitation

The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management

17 Feb 2024 – From PCR Tokyo Valves 2024

This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...

The optimal first valve

TAVI for bicuspid aortic stenosis patients - Recorded cases

05 Dec 2023 – From GulfPCR-GIM 2023

Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.

  • An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
TAVI for bicuspid aortic stenosis patients - LIVE case

Welcome to GulfPCR Valves 2023

05 Dec 2023 – From GulfPCR-GIM 2023

Find out more about this very first edition of GulfPCR Valves by discovering its Course directors, its objectives, its programme, its partners and its interactivity. If you are a heart valve interventionist or an imager, and you have a keen interest in valve disease, and TAVI in...

Welcome to GulfPCR Valves 2023

Essentials of lifetime management of TAVR patients using novel Myval THV

05 Dec 2023 – From GulfPCR-GIM 2023

Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...

Essentials of lifetime management of TAVR patients using novel Myval THV

Newer generation self-expanding platform: technical optimisation for common clinical challenges

05 Dec 2023 – From GulfPCR-GIM 2023

The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...

Newer generation self-expanding platform: technical optimisation for common clinical challenges

Evidence gap and new indications

05 Dec 2023 – From GulfPCR-GIM 2023

Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...

Evidence gap and new indications

TAVI and access: alternating is wise

16 Jan 2024 – From GulfPCR-GIM 2023

Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...

TAVI and access: alternating is wise

From access to annulus: overcoming challenging anatomies

05 Dec 2023 – From GulfPCR-GIM 2023

Gain expertise in selecting the appropriate TAVI device for achieving stable deployment in a 90-degree horizontal aorta. Discover techniques for ensuring smooth deliverability, particularly when navigating through tight and tortuous anatomies. Additionally, learn strategies to prepare for future coronary access, irrespective of the height of the...

From access to annulus: overcoming challenging anatomies

Valve-in-valve: not as simple as it looks

05 Dec 2023 – From GulfPCR-GIM 2023

Thanks to this session, you will enhance your comprehension of anticipating, planning, and executing TAV-in-TAV procedures, and gain insights into preventing coronary obstruction during these interventions.

Valve-in-valve: not as simple as it looks

Next-generation complex PCI toolkit and novel balloon expandable Myval THV

06 Dec 2023 – From GulfPCR-GIM 2023

This session is a valuable resource for grasping innovative strategies in handling bifurcation and extended diffuse lesions through dedicated stenting solutions. Explore insights into the advanced Myval next-generation THV technology, unveiling its distinctive features, procedural advantages, and clinical outcomes across a diverse patient pool. Gain understanding...

Next-generation complex PCI toolkit and novel balloon expandable Myval THV
Didn’t find what you were looking for?